Optimizing Outcomes in Advanced NSCLC

Access Course

 

886629.jpg?interpolation=lanczos-none&resize=300:225

Test your knowledge by helping manage this patient's newly diagnosed NSCLC.


This activity is intended for hematologists/oncologists and pulmonologists.
 

The goal of this activity is to improve providers' performance related to first-line treatment selection and management of patients with advanced NSCLC

 

 

 

 

Approximate Time to Complete: 30 minutes 

 

Course Available Beginning: Oct. 25, 2017

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Select the most appropriate treatment regimen for a patient with advanced non-small cell lung cancer (NSCLC) based on patient and tumor characteristics
  • Recognize immune-related adverse events in a patient with advanced NSCLC
Accreditation Council For Continuing Medical Education
AMA PRA Category 1 Credit(s)™: 0.50
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 0.50